Post-Pandemic Expansion: Opportunities in Non-Invasive Drug and Alcohol Screening
The global rapid oral fluid screening device market was valued at USD 5.38 billion in 2019 and is expected to grow at a CAGR of 20.7% during the forecast period, reflecting a transformative shift in substance detection methodologies driven by non-invasive sampling, regulatory modernization, and rising demand for point-of-care diagnostics. This growth trajectory is not uniform across...
0 Комментарии 0 Поделились 463 Просмотры 0 предпросмотр